The blockbuster GLP-1 drugs that have reshaped the treatment of diabetes and obesity may help prevent multiple substance use disorders — and reduce the tragic outcomes they cause, a large new study finds. An analysis published Wednesday in a medical journal looked
December 14, 2023 (Associated Press): A large Swedish study has uncovered a paradox about people diagnosed with an excessive fear of serious illness. They tend to die earlier than people who aren’t hypervigilant about health concerns. Hypochondriasis, now called illness anxiety disorder,
The review into the National Disability Insurance Scheme (NDIS) has been released and it recommends some big changes. This is not a report that just moves the deck chairs – it changes the whole layout of the ship, including its approach to
New Delhi, December 11, 2023: If you like nothing more than a hot cup of tea with a plate of eggs at breakfas, we’re really sorry but we have bad news for your health. While you don’t need to chuck your tea
Waltham, Massachusetts,( United States), December 7, 2023: A common drug used for rheumatoid arthritis – baricitinib – has shown promising results for patients with type 1 diabetes. A world-first trial, published in The New England Journal of Medicine, showed baricitinib could limit
